IVO 250 (Tibsovo 250 mg)
Generic Name: ivosidenib
Pill with imprint IVO 250 is Blue, Elliptical/Oval and has been identified as Tibsovo 250 mg. It is supplied by Agios Pharmaceuticals, Inc.
Tibsovo is used in the treatment of acute myeloid leukemia; biliary tract tumor and belongs to the drug class miscellaneous antineoplastics. Tibsovo 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IVO 250
Tibsovo
- Generic Name
- ivosidenib
- Imprint
- IVO 250
- Strength
- 250 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Agios Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71334-0100
More about Tibsovo (ivosidenib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Pricing & coupons
- En español
- Drug class: miscellaneous antineoplastics
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.